Trial Profile
Randomized clinical trial to evaluate the efficacy of aspirin in primary prevention of cardiovascular disease in individuals over 50 years with type 2 diabetes
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Aug 2011
Price :
$35
*
At a glance
- Drugs Aspirin (Primary)
- Indications Cardiovascular disorders; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms DM-AAS
- 26 Aug 2011 New trial record